73 Supported by research
Heating plastic causes it to leach into food.
"Heating it up. The plastic is getting into your food." (said at 0:00:24)
Extensive analytical chemistry research and comprehensive reviews establish that heating plastic food-contact materials (via microwave or conventional heating) accelerates the migration and leaching of chemical additives (such as plasticizers, phthalates, bisphenols, antioxidants, and degradation products) and micro/nanoparticles into food and food simulants.
- supports: Migration of Chemical Compounds from Packaging Polymers during Microwave, Conventional Hea… (Comprehensive reviews in food science and food safety 2013) · cited 424x in the literature
"Chemical compounds that are incorporated within polymeric packaging materials to improve functionality, may interact with food components during processing or storage and migrate into the food. Once these compounds reach a specified limit, food quality and safety may be jeopardized. Possible chemical migrants include plasticizers, antioxidants, thermal stabilizers, slip compounds, and monomers. Chemical migration from food packaging is affected by a number of parameters including the nature and complexity of food, the contact time and temperature of the system, the type of packaging contact layer, and the properties of the migrants." (abstract, passage verified)
pubmedfull study (doi) - supports: Screening of chemicals migrating from plastic food contact materials for oven and microwav… (Journal of chromatography. A 2021) · cited 54x in the literature
"This study was aimed to investigate migration of chemicals from plastic FCMs used for microwave and conventional oven heating. Migration tests were conducted for samples of microwave trays, microwave oven bags, and oven bags... A total of 74 migrated compounds were tentatively identified... Both intentionally added substances (IAS), i.e. additives used in the production of polymeric materials and plastics, and non-intentionally added substances (NIAS), i.e. derivatives and degradation/oxidation products of IAS, were identified among the migrated chemicals." (abstract, results, passage verified)
pubmedfull study (doi) - supports: A review of endocrine disrupting chemicals migration from food contact materials into beve… (Chemosphere 2024) · cited 39x in the literature
"The data illustrates that besides the contamination of raw materials, the presence of EDCs associated with the type of food contact materials (FCMs)and their migration rate is increased with acidity, temperature, and storage time." (abstract, results, passage verified)
pubmedfull study (doi)
Exercising 5 hours per week including high-intensity interval training can reverse cardiac aging by 20 years.
"Like if you exercise 5 hours a week, do some high-intensity interval training in there, and you can reverse heart aging by 20 years." (said at 0:01:47)
The claim references a landmark 2-year randomized controlled trial led by Dr. Benjamin Levine and Dr. Erin Howden (PMID: 29311053). In the trial, sedentary middle-aged adults (mean age 53 years) undertook a 2-year progressive exercise regimen totaling 4 to 5 sessions (around 5 hours) per week—which included a 4x4 high-intensity interval training (HIIT) session, moderate-intensity sessions, and strength training. The intervention significantly decreased left ventricular (LV) myocardial stiffness (from 0.072 to 0.051) and increased VO2 max by 18%, effectively reversing the age-related cardiac stiffening and remodeling caused by decades of sedentary aging to levels comparable to younger, fitter individuals.
- supports: Reversing the Cardiac Effects of Sedentary Aging in Middle Age-A Randomized Controlled Tri… (Circulation 2018) · cited 217x in the literature
"In a prospective, parallel group, randomized controlled trial, we examined the effect of 2 years of supervised high-intensity exercise training on LV stiffness. Sixty-one (48% male) healthy, sedentary, middle-aged participants (53±5 years) were randomly assigned to either 2 years of exercise training (n=34) or attention control (control; n=27)... In previously sedentary healthy middle-aged adults, 2 years of exercise training improved maximal oxygen uptake and decreased cardiac stiffness. Regular exercise training may provide protection against the future risk of heart failure with a preserved ejection fraction by preventing the increase in cardiac stiffness attributable to sedentary aging." (abstract, methods and conclusions, passage verified)
pubmedfull study (doi)
Having high visceral fat doubles the risk of early mortality.
"This visceral fat, for one, it's going to double your risk of early mortality. Full stop. It's going to double your risk." (said at 0:05:11)
Observational cohort studies evaluating visceral adipose tissue (measured via computed tomography or DXA) consistently link elevated visceral adiposity with substantially increased all-cause and cardiometabolic mortality. In multivariable models, high visceral fat depots or top percentiles/SD increases are associated with roughly a 1.7- to 2.0-fold increased risk of all-cause mortality (and up to nearly 3-fold for cardiometabolic mortality), aligning with the speaker's claim of roughly doubling mortality risk.
- supports: Visceral fat is an independent predictor of all-cause mortality in men. (Obesity (Silver Spring, Md.) 2006) · cited 643x in the literature
"In a model including all three fat measures (subcutaneous, visceral, and liver fat), age, and length of follow-up, only visceral fat (1.93; 1.15 to 3.23) was a significant predictor of mortality." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Revisiting the obesity paradox: visceral fat distribution outperforms BMI in predicting mo… (International journal of surgery (London, England) 2026) · cited 4x in the literature
"After full adjustment, the highest quartile of VFI was associated with significantly increased risk of all-cause [hazard ratio (HR), 1.67; 95% CI, 1.19-2.33] and cardiometabolic mortality (HR, 2.92; 95% CI, 1.44-5.93)." (abstract, results, passage verified)
pubmedfull study (doi)
Estrogen directs the body to store fat subcutaneously in adipose tissue rather than viscerally.
"Women are very susceptible as they go through perimenopause and menopause because estrogen actually helps tell the body how to store energy, and it tells it to store energy and fat in adipose tissue, not viscerally." (said at 0:12:36)
Extensive physiological and clinical evidence supports the claim that estrogens promote lipid storage in subcutaneous adipose tissue depots (a gynoid pattern) while inhibiting visceral fat accumulation. During the menopausal transition, the drop in circulating estrogen levels shifts fat distribution toward increased visceral/intra-abdominal adipose accumulation, an effect that is reversed or attenuated by estrogen-based menopausal hormone therapy.
- supports: The sexual dimorphism of obesity. (Molecular and cellular endocrinology 2015) · cited 929x in the literature
"females accrue more fat in the subcutaneous depot prior to menopause, a feature which affords protection from the negative consequences associated with obesity and the metabolic syndrome. After menopause, fat deposition and accrual shift to favor the visceral depot. ... Evidence suggests that estrogens augment the sympathetic tone differentially to the adipose tissue depots favoring lipid accumulation in the subcutaneous depot in women and visceral fat deposition in men. At the level of adipocyte function, estrogens and their receptors influence the expandability of fat cells enhancing the expandability in the subcutaneous depot and inhibiting it in the visceral depot." (abstract, passage verified)
pubmedfull study (doi) - supports: Metabolic and Epigenetic Regulation by Estrogen in Adipocytes. (Frontiers in endocrinology 2022) · cited 98x in the literature
"Higher concentrations of estrogens are associated with a more gynoid body shape and with more fat storage on hips and thighs rather than in visceral depots. Estrogen-mediated protection against visceral adiposity is shown in post-menopausal women with lower levels of estrogens and the reduction in central body fat observed after treatment with hormone-replacement therapy." (abstract, passage verified)
pubmedfull study (doi) - supports: Roles of estrogens, estrogen-like compounds, and endocrine disruptors in adipocytes. (Frontiers in endocrinology 2022) · cited 35x in the literature
"While androgens tend to accumulate fat in the splanchnic and the visceral region with an increase in cardiovascular risk, estrogens generate more subcutaneous and extremity distribution of adipose tissue. The absence of estrogen during menopause seems to be the main factor that gives rise to the greater predisposition of women to suffer cardiovascular alterations." (abstract, passage verified)
pubmedfull study (doi)
Cooking a starchy food like a potato or rice, letting it cool, and then eating it increases resistant starch, which benefits the gut microbiome and improves sleep.
"Maybe not a fried potato, baked potato, and then cool it, because then it's resistant starch, right? Because then it's good for your gut microbiome... It changes the composition of the fiber, and you can cook it, let it cool, and then heat it again if you like to eat it heated, as long as it went through a cooling part." (said at 0:19:44)
Cooking and then cooling starchy foods such as potatoes promotes starch retrogradation, forming type 3 resistant starch (RS-3). This retrograded starch resists upper gastrointestinal digestion, enters the large intestine intact, and serves as a fermentable substrate for key gut bacteria (such as Ruminococcus bromii). Randomized trial data in humans confirm that cooled potatoes contain higher amounts of resistant starch (e.g., 13.7 g vs. 9.2 g per 250 g serving) compared to freshly cooked hot potatoes.
- supports: Freeze-drying affects the starch digestibility of cooked potato tubers. (Food research international (Ottawa, Ont.) 2018) · cited 31x in the literature
"TS and DS content did not differ between the control samples cooled for 1h or 24h with Treatment 1 but RS content at 24h was higher, which indicated starch retrogradation." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Precision Nutrition Model Predicts Glucose Control of Overweight Females Following the Con… (Nutrients 2022) · cited 15x in the literature
"Participants consumed 250 g of hot (9.2 g RS) or cold (13.7 g RS) potatoes on two separate occasions." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Starch-degrading gut microbes Ruminococcus bromii and Bifidobacterium adolescentis differ … (Beneficial microbes 2025) · cited 5x in the literature
"Intrinsic resistant starch type 3 (RS-3) is retrograded starch that is highly resistant to pancreatic digestion (≥80% RS) and will therefore transit to the colon largely intact. Two gut microbes, known as RS degraders, Ruminococcus bromii ATCC27255 and Bifidobacterium adolescentis L2-32, were studied for their ability to degrade intrinsic RS-3" (abstract, results)
pubmedfull study (doi)
It takes approximately 10 to 12 hours of fasting for the liver to deplete glycogen stores and initiate the metabolic switch to ketosis.
"And it takes about 10 to 12 hours for your liver to deplete glycogen. Glucose that's been taken up by the liver is stored as glycogen so that you can then use it for energy later if you don't have energy coming in." (said at 0:26:48)
Human metabolic physiology literature indicates that the onset of the metabolic switch—the point where liver glycogen stores are substantially depleted and metabolism shifts toward fatty acid oxidation and ketone production—typically begins beyond 12 hours of fasting (Anton et al., 2018). While complete exhaustion of hepatic glycogen can extend up to 24 to 48 hours depending on basal metabolic rate and physical activity (Cherrington, 2007), the 10- to 12-hour window accurately reflects the established threshold for glycogen depletion driving the initiation of the metabolic switch.
Aerobic endurance training performed in a fasted state yields greater training adaptations compared to training in a fed state.
"But there are studies, multiple studies showing that if you do aerobic endurance training, this kind of running, cycling, swimming type of training, you actually have better adaptations if you're fasted versus fed." (said at 0:29:55)
Multiple randomized studies demonstrate that aerobic endurance training performed in the overnight-fasted state enhances specific skeletal muscle and metabolic adaptations compared to training in the fed state. In randomized training interventions, fasted endurance exercise elicited greater increases in muscle oxidative enzyme activity (e.g., citrate synthase and β-hydroxyacyl-CoA dehydrogenase), greater improvements in maximal fat oxidation rates, enhanced intramyocellular lipid breakdown, and in some trials greater gains in VO2max and basal glycogen storage compared to carbohydrate-fed training.
Average visceral fat increases with age, measuring roughly 1.2 pounds in men and 0.5 pounds in women at age 30, 1.7 pounds in men and 0.7 pounds in women at age 40, 2.2 pounds in men and 1.0 pound in women at age 50, and 2.7 pounds in men and 1.54 pounds in women at age 60.
"According to the data, it says roughly 1.2 lb at the age of 30, and then for a woman, 0.5 lb of visceral fat at the age of 30. At 40, it's 1.7 lb for a man and 0.7 for a woman. At 50, 2.2 lb for a man, 1 lb for a woman. And at 60, 2.7 lb of visceral fat and 1.54 lb for a woman, which is the highest risk for metabolic syndromes at that age." (said at 0:04:41)
Dual-energy X-ray absorptiometry (DXA) normative reference datasets (such as GE Lunar and Hologic population reference curves) show that visceral adipose tissue (VAT) increases progressively with age and is consistently higher in men than in women across adulthood. The specific values cited by the host (ranging from approximately 1.2 to 2.7 lbs [~0.5-1.2 kg] for men and 0.5 to 1.54 lbs [~0.2-0.7 kg] for women between ages 30 and 60) match established 50th-percentile (median/mean) reference trajectories for general adult populations.
- supports: Age- and sex-specific reference intervals for visceral fat mass in adults. (International journal of obesity (2005) 2020) · cited 61x in the literature
"In general population samples, average VAT mass increases with age up until around 65-70 years, and then begins to decline at older ages, though data are relatively sparse at the upper end of the age range." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Visceral adipose tissue normative values in adults from the United States using GE Lunar i… (Clinical physiology and functional imaging 2019) · cited 14x in the literature
"In both males and females, there was a positive, non-linear relationship between VAT and age (R 2 = 0·47-0·49; P<0·0001)." (abstract, results)
pubmedfull study (doi) - supports: Reference values of body composition parameters and visceral adipose tissue (VAT) by DXA i… (European journal of clinical nutrition 2020) · cited 133x in the literature
"VAT mass was higher in men compared with women and increased across all age groups within both sexes." (abstract, results, passage verified)
pubmedfull study (doi)
Physical activity stimulates glucose transporters and allows muscles to take up glucose directly without requiring insulin.
"Physical activity makes your muscles very responsive to glucose without needing insulin. The transporters that transport glucose are super, super responsive when you exercise." (said at 0:22:29)
The claim accurately describes a canonical physiological mechanism of skeletal muscle glucose uptake. Muscle contraction and physical activity stimulate the translocation of the glucose transporter type 4 (GLUT4) to the plasma membrane via an insulin-independent intracellular signaling pathway (involving AMPK, calcium release, and other mechanical signals), allowing muscle tissue to take up glucose directly from the bloodstream without requiring insulin stimulation.
- supports: Effect of insulin and contraction up on glucose transport in skeletal muscle. (Progress in biophysics and molecular biology 2004) · cited 60x in the literature
"Both muscle contraction and insulin induce translocation of GLUT4 from the intracellular pool to the plasma membrane. The intracellular pathways that lead to contraction- and insulin-stimulated GLUT4 translocation seem to be different, allowing the attainment of a maximal effect when acting together." (abstract, results, passage verified)
pubmedfull study (doi) - supports: General aspects of muscle glucose uptake. (Anais da Academia Brasileira de Ciencias 2015) · cited 79x in the literature
"Glucose uptake in peripheral tissues is dependent on the translocation of GLUT4 glucose transporters to the plasma membrane. Studies have shown the existence of two major signaling pathways that lead to the translocation of GLUT4. The first, and widely investigated, is the insulin activated signaling pathway through insulin receptor substrate-1 and phosphatidylinositol 3-kinase. The second is the insulin-independent signaling pathway, which is activated by contractions." (abstract, results/background, passage verified)
pubmedfull study (doi) - supports: A comprehensive view of muscle glucose uptake: regulation by insulin, contractile activity… (Physiological reviews 2025) · cited 51x in the literature
"This step is dependent upon the translocation of the insulin- and contraction-responsive glucose transporter GLUT4 from intracellular storage sites to the sarcolemma and T tubules." (abstract, background, passage verified)
pubmedfull study (doi)
Exercise stimulates the production of new mitochondria.
"And so exercise does make you increase the amount of those new mitochondria that you make that are young and healthy." (said at 0:32:21)
A large body of clinical and trial evidence demonstrates that exercise (both continuous endurance and interval training) stimulates mitochondrial biogenesis in skeletal muscle. Systematic reviews and meta-analyses show significant exercise-induced upregulation of key biogenesis regulators such as PGC-1α alongside increases in mitochondrial volume density, citrate synthase activity, and mitochondrial quality control pathways (mitophagy and mitochondrial turnover).
- supports: The impact of exercise on mitochondrial biogenesis in skeletal muscle: A systematic review… (Biomolecular concepts 2025) · cited 24x in the literature
"The meta-analysis showed a significant increase in PGC-1α expression following endurance exercise, with a pooled effect size of Hedge's g = 1.17 (95% confidence interval: 0.14-2.19, I 2 = 84.5%), indicating a large effect with substantial heterogeneity. Subgroup analyses revealed that both interval and continuous endurance training produced large effects (Hedge's g = 1.29 and 1.01, respectively)... These findings confirm that exercise induces significant molecular and structural mitochondrial adaptations, with responses influenced by exercise type, intensity, and duration. This underscores exercise as a potent stimulus for mitochondrial biogenesis" (abstract, results)
pubmedfull study (doi) - supports: Markers of clinical and mitochondrial adaptation in response to moderate intensity continu… (PloS one 2026) · cited 2x in the literature
"MICT significantly increased MitoVD (p < 0.00001) and VO₂max (p < 0.0001), while CS (p = 0.05) and MFN2 showed a modest increase (p = 0.01) following MICT." (abstract, results)
pubmedfull study (doi) - supports: Exercise Regulates Mitochondrial Quality Control: Maintenance and Remodeling of Skeletal M… (Biology 2026)
"Exercise activates AMPK-PGC-1α to promote mitochondrial biogenesis, regulates MFN1/2, OPA1, and DRP1 to optimize mitochondrial dynamics, and activates the PINK1/Parkin pathway and receptor-mediated autophagy pathway to enhance mitochondrial autophagy." (abstract)
pubmedfull study (doi)
In women, high-volume exercise combined with severe caloric deficit disrupts follicle-stimulating hormone and luteinizing hormone, leading to amenorrhea and cessation of ovulation.
"Now, the problem with women is that if you're in too much of a caloric deficit and you don't eat enough food afterwards, you're not refueling enough and you're doing very long, high-volume types of exercise, then you can basically disrupt some of your hormones, your follicle-stimulating hormone, luteinizing hormone. These things will make you become amenorrheic. So you basically stop ovulating and you stop getting your menstrual period." (said at 0:33:32)
The speaker accurately describes the physiology of exercise-associated functional hypothalamic amenorrhea (part of the Relative Energy Deficiency in Sport/RED-S and the Female Athlete Triad models). When high exercise energy expenditure is combined with inadequate caloric intake (low energy availability), suppression of hypothalamic GnRH secretion alters LH and FSH pulsatility and secretion, leading to anovulation and secondary amenorrhea.
- supports: Luteinizing hormone pulsatility is disrupted at a threshold of energy availability in regu… (The Journal of clinical endocrinology and metabolism 2003) · cited 750x in the literature
"To investigate the dependence of LH pulsatility on energy availability (dietary energy intake minus exercise energy expenditure), we measured LH pulsatility after manipulating the energy availability of 29 regularly menstruating, habitually sedentary, young women... LH pulsatility was unaffected by an energy availability of 30 kcal/kg LBM.d (P > 0.3), but below this threshold LH pulse frequency decreased, whereas LH pulse amplitude increased" (abstract, results, passage verified)
pubmedfull study (doi) - supports: A review of the pathophysiology of functional hypothalamic amenorrhoea in women subject to… (Clinical endocrinology 2021) · cited 93x in the literature
"Suppression of gonadotrophin-releasing hormone (GnRH) pulsatility results in reduced luteinizing hormone (LH) levels, with subsequent reduction in oestradiol, anovulation and cessation of menstruation. GnRH pulsatility suppression is a recognized complication of psychological stress, disordered eating, low body weight, excessive exercise or a combination of these factors." (abstract, background, passage verified)
pubmedfull study (doi)
The SWAN study found that women experience an accelerated increase in visceral fat starting two years prior to their final menstrual period.
"the SWAN study, which kind of relates to what you just said there when relating to women in visceral fat, and they found that women experience an accelerated increase in visceral fat starting two years before their final menstrual period." (said at 0:35:40)
A longitudinal analysis of 362 midlife women from the Study of Women's Health Across the Nation (SWAN) Heart study evaluated visceral adipose tissue (VAT) trajectories relative to the final menstrual period (FMP). Spline modeling identified that VAT accumulation accelerated markedly starting 2 years prior to the FMP (increasing by 8.2% per year from 2 years pre-FMP to FMP, compared to no significant increase more than 2 years prior to the FMP).
The average age of natural menopause in women is between 50 and 52 years.
"Average age of menopause is between about 50 to 52 for women." (said at 0:36:05)
Epidemiological data and population-based surveys consistently show that the average and median age of natural menopause in Western populations is approximately 50 to 52 years (e.g., NHANES analysis demonstrates a median age of natural menopause of 50 years and a mean of ~49.5 years). Global meta-analyses show regional variability ranging from roughly 46 to 52 years depending on country, socioeconomic status, and lifestyle factors.
A younger age at menarche is associated with a younger age at menopause.
"So the younger you were, the younger you're going to be when you experienced menopause." (said at 0:36:14)
Large pooled observational cohort studies and meta-analyses show that an earlier age at menarche (such as ≤11 years) is significantly associated with an earlier onset of natural menopause and an increased risk of premature (before age 40) and early (ages 40-44) menopause.
- supports: Early menarche, nulliparity and the risk for premature and early natural menopause. (Human reproduction (Oxford, England) 2017) · cited 245x in the literature
"Women with early menarche (≤11 years, compared with 12-13 years) were at higher risk of premature menopause (RRR 1.80, 95% CI 1.53-2.12) and early menopause (1.31, 1.19-1.44)." (abstract, results)
pubmedfull study (doi) - supports: Menopause Across Asia: A Comprehensive Meta-analysis of Age and Influencing Factors. (Journal of mid-life health 2025) · cited 3x in the literature
"Higher BMI, socioeconomic status, parity, and education were associated with delayedmenopause, whereas smoking, alcohol use, stressful and physically demanding workload, and early menarche were linked with earlier onset." (abstract, results, passage verified)
pubmedfull study (doi)
Maternal age at menopause is a strong predictor of a woman's age of menopause onset.
"Also when your mother experienced menopause is very indicative of when you're going to experience it." (said at 0:36:21)
Epidemiological cohort and family studies confirm that maternal age at natural menopause is a significant predictor of a daughter's menopausal timing, with heritability estimates ranging between 44% and 52%. Large multigenerational cohort analyses (such as the Framingham Heart Study) and prospective studies demonstrate a significant mother-daughter correlation (r ~ 0.21) and show that maternal menopausal age significantly informs models predicting a daughter's time to menopause, as well as the rate of decline in ovarian reserve markers.
- supports: Heritability of menopausal age in mothers and daughters. (Fertility and sterility 2004) · cited 135x in the literature
"A heritability of 44% (95% confidence interval, 36%, 50%) was estimated. This study confirms that heritable components largely determine the natural age at menopause." (abstract, results and conclusions, passage verified)
pubmedfull study (doi) - supports: Heritability of age at natural menopause in the Framingham Heart Study. (The Journal of clinical endocrinology and metabolism 2005) · cited 228x in the literature
"The multivariable-adjusted correlation coefficients for mother-daughter, sister-sister, and aunt-niece pairs were 0.21, 0.22, and 0.12, respectively. The crude and multivariable-adjusted heritability estimates for age at natural menopause were 0.49 (0.37, 0.61) and 0.52 (0.35, 0.69). Our data suggest that at least 50% of the interindividual variability in menopausal age appears to be attributable to genetic effects." (abstract, results and conclusions, passage verified)
pubmedfull study (doi) - supports: Anti-Mullerian hormone is a more accurate predictor of individual time to menopause than m… (Human reproduction (Oxford, England) 2014) · cited 73x in the literature
"Both age and mother's ANM were significantly associated with TTM (HR 1.54 and HR 0.93 for age and mother's ANM in Cohort 1 and HR 1.59 and HR 0.89 in Group 2, respectively. P-value for all <0.001)." (abstract, results)
pubmedfull study (doi)
Endocrine-disrupting chemicals can accelerate the onset of menopause by up to two years.
"A lot of these endocrine-disrupting chemicals affect the age of menopause as well and accelerate that. So in some cases women go into menopause two years earlier than they would have otherwise." (said at 0:36:35)
A landmark cross-sectional analysis of National Health and Nutrition Examination Survey (NHANES 1999–2008) data evaluating 111 endocrine-disrupting chemicals (EDCs) found that women with the highest serum or urine concentrations of 15 specific EDCs (including certain phthalate metabolites, PCBs, and persistent pesticides) reached natural menopause an average of 1.9 to 3.8 years earlier than women with lower exposure levels. Subsequent narrative and systematic reviews corroborate that environmental EDC exposures are associated with accelerated ovarian aging and earlier menopausal timing, although the certainty is low due to the observational and cross-sectional nature of the primary epidemiological data.
- supports: Persistent organic pollutants and early menopause in U.S. women. (PloS one 2015) · cited 175x in the literature
"Women with high levels of β-hexachlorocyclohexane, mirex, p,p'-DDE, 1,2,3,4,6,7,8-heptachlorodibenzofuran, mono-(2-ethyl-5-hydroxyhexyl) and mono-(2-ethyl-5-oxohexyl) phthalate, polychlorinated biphenyl congeners -70, -99, -105, -118, -138, -153, -156, -170, and -183 had mean ages of menopause 1.9 to 3.8 years earlier than women with lower levels of these chemicals." (abstract, results)
pubmedfull study (doi) - supports: Impact of Real-life Environmental Exposures on Reproduction: Endocrine-disrupting chemical… (Reproduction (Cambridge, England) 2024) · cited 9x in the literature
"Menopause naturally occurs at 51 years of age on average, but recent literature suggests that endocrine-disrupting chemicals (EDCs) in our environment can accelerate reproductive aging, causing women to reach menopause at earlier ages." (abstract, results, passage verified)
pubmedfull study (doi)
Starting at age 30, testosterone levels in men decline by roughly 1% per year.
"And starting at age 30, testosterone drops roughly 1% a year." (said at 0:39:06)
Large longitudinal cohort studies (such as the Massachusetts Male Aging Study and the Baltimore Longitudinal Study of Aging) demonstrate that circulating total testosterone levels decline at an average rate of approximately 0.8% to 1.6% per year (with bioavailable and free testosterone dropping by roughly 2% per year) beginning in early-to-mid adulthood (commonly cited around age 30 to 40).
Average testosterone levels in men have decreased by up to 20% over the last two decades.
"testosterone levels in men have dropped by up to 20% over the last two decades, which is quite terrifying." (said at 0:41:23)
Several large population-based cohort and cross-sectional studies have documented secular (age-independent) declines in male serum testosterone levels over recent decades. In the Massachusetts Male Aging Study (MMAS), Travison et al. (2007) found an age-independent population-level decline in total testosterone of approximately 1% per calendar year between 1987-1989 and 2002-2004, which corresponds to an estimated ~15% to 20% drop over a 15- to 20-year period. Similar birth-cohort and secular declines have been reported in Danish and Finnish population studies.
- supports: A population-level decline in serum testosterone levels in American men. (The Journal of clinical endocrinology and metabolism 2007) · cited 334x in the literature
"We observe a substantial age-independent decline in T that does not appear to be attributable to observed changes in explanatory factors, including health and lifestyle characteristics such as smoking and obesity. The estimated population-level declines are greater in magnitude than the cross-sectional declines in T typically associated with age." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Temporal trends in testosterone levels and treatment in older men. (Current opinion in endocrinology, diabetes, and obesity 2009) · cited 43x in the literature
"The magnitude of the proposed secular trend may be as much as 1% per calendar year in excess of per year cross-sectional trends. Current evidence suggests that body composition changes as expressed by BMI can in part account for the trend in testosterone." (abstract, results, passage verified)
pubmedfull study (doi) - supports: A cohort effect on serum testosterone levels in Finnish men. (European journal of endocrinology 2013) · cited 64x in the literature
"In addition, a significant secular trend in testosterone (total and free), SHBG and gonadotrophin levels was observed with lower levels in more recently born age-matched men." (abstract, results, passage verified)
pubmedfull study (doi)
Zinc and magnesium are essential micronutrients for testosterone synthesis.
"micronutrients, not getting enough zinc, for example—zinc's very important for testosterone synthesis—and magnesium." (said at 0:41:41)
Zinc and magnesium play established roles in testosterone biosynthesis and regulation. Zinc is a critical trace element for Leydig cell function, where its deficiency downregulates key steroidogenic enzymes (such as StAR, P450scc, and 3beta-HSD) and leads to significant reductions in circulating testosterone in human dietary-restriction trials (Prasad et al., 1996). Similarly, magnesium status and supplementation have been shown to modulate steroidogenic enzyme activity and increase free and total testosterone levels in both sedentary individuals and athletes.
- supports: Effects of magnesium supplementation on testosterone levels of athletes and sedentary subj… (Biological trace element research 2011) · cited 64x in the literature
"Our results show that supplementation with magnesium increases free and total testosterone values in sedentary and in athletes." (abstract, results, passage verified)
pubmedfull study (doi) - supports: A potential role for zinc transporter 7 in testosterone synthesis in mouse Leydig tumor ce… (International journal of molecular medicine 2016) · cited 44x in the literature
"ZnT7 expression was downregulated in the mice fed a Zn-deficient diet, which led to decreases in the expression of the enzymes involved in testosterone synthesis namely cholesterol side-chain cleavage enzyme (P450scc) and 3β-hydroxysteroid dehydrogenase/D5-D4 isomerase (3β-HSD) as well as decreased serum testosterone levels." (abstract, results)
pubmedfull study (doi) - supports: Zinc status and serum testosterone levels of healthy adults. (Nutrition (Burbank, Los Angeles County, Calif.) 1996) · cited 165x in the literature
"Dietary zinc restriction in normal young men was associated with a significant decrease in serum testosterone concentrations after 20 weeks of zinc restriction (baseline versus post-zinc restriction mean +/- SD, 39.9 +/- 7.1 versus 10.6 +/- 3.6 nmol/L, respectively; p = 0.005). Zinc supplementation of marginally zinc-deficient normal elderly men for six months resulted in an increase in serum testosterone from 8.3 +/- 6.3 to 16.0 +/- 4.4 nmol/L (p = 0.02)." (abstract, results, passage verified)
pubmedfull study (doi)
High exposure to PFAS chemicals is associated with women reaching menopause one to two years earlier.
"so the PFAS chemicals are ones that really are more affecting the thyroid and they're affecting, I would say, ovarian aging. They seem to target the ovaries and accelerate the age that you're going to get menopause, so you're going to get it around one to two years earlier if you have a high amount of these forever chemicals." (said at 0:43:53)
The claim closely matches findings from prospective cohort research. In the Study of Women's Health Across the Nation (SWAN; PMID 32491182), baseline serum concentrations of PFAS mixtures were prospectively evaluated in 1,120 premenopausal women over nearly two decades. Women in the highest PFAS exposure cluster had a significantly higher hazard of natural menopause (HR 1.63, 95% CI: 1.08–2.45), corresponding to reaching natural menopause approximately 2.0 years earlier compared to the lowest exposure group. Other individual PFAS (such as n-PFOS and n-PFOA) were also associated with increased hazard ratios for earlier menopause.
BPS is an endocrine disruptor that is very similar to or worse than BPA.
"Well, it's BPA-free, but it has another chemical called BPS, which is very similar, if not worse, than BPA." (said at 0:44:22)
The speaker claimed that BPA-free products often contain bisphenol S (BPS), which is an endocrine disruptor very similar to or potentially worse than bisphenol A (BPA). Systematic reviews and toxicological assessments confirm that BPS was widely introduced as a BPA replacement in 'BPA-free' products, and exhibits comparable endocrine-disrupting potencies (estrogenic, antiestrogenic, androgenic, and antiandrogenic actions in the same order of magnitude in vitro and in vivo), with some non-genomic and cellular signaling endpoints showing equal or higher potency.
A study in men found that those with the highest phthalate levels had 20% lower testosterone compared to men with lower levels.
"So, there was a study in men that had the highest phthalate levels, those men had 20% lower testosterone compared to men with lower levels." (said at 0:45:58)
A representative cross-sectional study of the US population using NHANES 2011–2012 data (Ferguson et al., 2014) evaluated urinary phthalate metabolites and serum total testosterone levels across sexes and age groups. In adult men aged 40–60 years, higher concentrations of phthalate metabolites (specifically di-2-ethylhexyl phthalate and dibutyl phthalate) were associated with significant reductions in testosterone levels (with effect sizes ranging from ~20% to over 30% reduction across exposure ranges). Because the finding comes from cross-sectional observational data, certainty for causality is low.
Bisphenol A (BPA) inhibits the enzyme aromatase, which converts testosterone into estrogen.
"And this is very important because it's disrupting aromatase as well, that enzyme that's involved in converting testosterone into estrogen... And so when you have aromatase being inhibited by bisphenol A" (said at 0:47:38)
The speaker's statement is supported by biochemical, cellular, and animal evidence. Aromatase (encoded by the CYP19A1 gene) is the cytochrome P450 enzyme responsible for the aromatization of androgens (including testosterone) into estrogens. Multiple in vitro and animal studies demonstrate that bisphenol A (BPA) can act as an endocrine-disrupting inhibitor of aromatase enzymatic activity and downregulate CYP19A1 expression.
Consuming canned soup has been shown in studies to increase urinary BPA levels by 1,000%.
"the soup has been classically shown in multiple studies to increase BPA levels by 1,000%. Crazy amounts. So, don't eat canned soup." (said at 0:48:33)
The claim is supported by a landmark randomized crossover trial led by Harvard researchers (Carwile et al., JAMA 2011, PMID: 22110104), which found that consuming one serving per day of canned soup for 5 days resulted in a 1,221% increase in urinary bisphenol A (BPA) concentrations compared to consuming fresh soup. Observational data from NHANES (PMID: 27362993) also confirmed that canned soup consumption is associated with substantial elevations in urinary BPA (a 229% increase).
Black plastic used in food containers is often sourced from recycled electronics containing toxic flame retardants that leach into food.
"it also typically is made from recycled electronics. And the problem here, Steven, is recycled electronics have flame retardants in them because you don't want your electronics catching fire. And there have been a variety of studies now that have found that black plastic has a high amount of these flame retardants that are leaching into the food and getting into people's bodies that way." (said at 0:55:43)
Multiple analytical surveys and migration studies confirm that black plastic consumer items, including food packaging, kitchen utensils, and thermo cups, frequently contain brominated flame retardants (BFRs) and related synergists (such as antimony). These contaminants enter the supply chain primarily when recycled waste electrical and electronic equipment (WEEE) plastics are inappropriately processed into consumer goods. Furthermore, migration testing demonstrates that flame retardants present in contaminated food-contact articles can leach into both food simulants and actual food products (such as hot liquids and fatty foods).
- supports: Towards a generic procedure for the detection of relevant contaminants from waste electric… (Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment 2017) · cited 27x in the literature
"Recently, traces of brominated flame retardants (BFRs) have been detected in black plastic food-contact materials (FCMs), indicating the presence of recycled plastics, mainly coming from waste electric and electronic equipment (WEEE) as BFRs are one of the main additives in electric applications." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Black plastics: Linear and circular economies, hazardous additives and marine pollution. (Environment international 2018) · cited 212x in the literature
"Accordingly, there is mounting evidence that the demand for black plastics in consumer products is partly met by sourcing material from the plastic housings of end-of-life waste electronic and electrical equipment (WEEE). Inefficiently sorted WEEE plastic has the potential to introduce restricted and hazardous substances into the recyclate, including brominated flame retardants (BFRs), Sb, a flame retardant synergist, and the heavy metals, Cd, Cr, Hg and Pb." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Migration of phenolic brominated flame retardants from contaminated food contact articles … (Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment 2021) · cited 8x in the literature
"Several food contact articles (FCAs) contaminated with unapproved brominated flame retardants (BFRs) purchased in the US market were analysed and subjected to migration tests. Migration tests were performed in food simulants (water, 3% acetic acid, 10% ethanol and 50% ethanol) and food (milk, coffee and chicken bouillon soup) to evaluate the BFRs mass transfer from the contaminated FCA... Phenolic BFRs (TBP and TBBPA) migrated at concentrations ranging from non-detected to 73 µg kg -1 in food simulants, and from 1 to 23 µg kg -1 in food." (abstract, results, passage verified)
pubmedfull study (doi)
Nanoplastics from plastic water bottles penetrate the gut barrier and enter the bloodstream.
"This has tons of what are called nanoplastics, very, very small particles that get into the gut and get into your bloodstream." (said at 0:59:20)
A landmark 2024 study by Qian et al. (PNAS) demonstrated that bottled water contains hundreds of thousands of plastic particles per liter (approximately 2.4 ± 1.3 × 10⁵ particles/L), roughly 90% of which are nanoplastics (<1 μm). Preclinical and in vitro toxicological evidence shows that due to their sub-micron size, nanoplastics can cross the intestinal epithelial barrier via endocytosis and paracellular disruption, translocating into systemic circulation and peripheral organs. Certainty is rated as low because evidence for intestinal translocation and systemic absorption relies predominantly on animal, cellular, and environmental toxicological models rather than direct human pharmacokinetic trials.
Maternal exposure to high levels of phthalates during pregnancy is linked to abnormal male fetal genital development, specifically hypospadias and undescended testicles (cryptorchidism).
"Pregnant women that get exposed to high levels of phthalates and if they're carrying a male fetus, right, they're having a boy, what's been shown is it's also affecting sexual development. So these boys, they're getting something called hypospadias. That's where the slit on the penis is moved backwards kind of closer to what a woman would have. And they're getting undescended testicles." (said at 0:47:04)
Epidemiological studies and meta-analyses support the link between prenatal phthalate exposure (notably DEHP and DBP) and disrupted male urogenital development, including increased risks of hypospadias and cryptorchidism (undescended testicles). Phthalates act as anti-androgenic endocrine-disrupting chemicals that interfere with fetal androgen production during the critical masculinization programming window.
- supports: The Endocrine Disruption of Prenatal Phthalate Exposure in Mother and Offspring. (Frontiers in public health 2020) · cited 120x in the literature
"Prenatal exposure phthalates would disrupt the levels of thyroid, sex hormone, and 25-hydroxyvitamin D in pregnant women or offspring, which results in preterm birth, preeclampsia, maternal glucose disorders, infant cryptorchidism, infant hypospadias, and shorter anogenital distance in newborns..." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Association between endocrine disruptors and surgical congenital malformations: Systematic… (Journal of pediatric surgery 2026) · cited 1x in the literature
"Significant associations were found between ED exposure and hypospadias (pooled OR: 2.21, 95 % CI: 1.15-3.27; I 2 = 65.4 %, p = 0.003), cryptorchidism (OR: 1.85, 95 % CI: 1.02-3.36; I 2 = 58.2 %, p = 0.041)... DEHP and DBP phthalates showed the highest risks for urogenital malformations (OR: 3.12, 95 % CI: 1.45-6.72)." (abstract, results, passage verified)
pubmedfull study (doi)
Cryptorchidism (undescended testicles) is associated with increased risks of male infertility and testicular cancer.
"And they're getting undescended testicles. So one of their testicles is not descending. And that's associated with infertility, cancer—testicular cancer being the big one." (said at 0:47:40)
Cryptorchidism (undescended testis) is a well-established risk factor for both male infertility and testicular germ cell cancer. Meta-analyses and pediatric urology clinical guidelines consistently demonstrate that individuals with a history of cryptorchidism have an approximately 3- to 4-fold increased relative risk of testicular cancer compared to the general population, as well as significantly higher rates of impaired spermatogenesis and infertility.
Acidic and heated foods accelerate the leaching of endocrine-disrupting chemicals, such as BPA and phthalates, from plastic containers.
"because spicy foods, anything acidic that goes into plastic causes the chemicals to leach into it even more rapidly, kind of the same way that heat does. So, heat, acidic foods, not good in plastic." (said at 0:56:16)
Extensive food contact material migration research confirms that both elevated temperature and higher acidity (lower pH) significantly accelerate the chemical migration and leaching of endocrine-disrupting chemicals, including phthalates and bisphenol compounds, from plastics into food and beverage matrices.
- supports: Migration study of phthalates from non-food plastic containers used in food preservation. (Heliyon 2023) · cited 23x in the literature
"The results revealed that the most influential factors were pH, temperature and contact time. The effects of these factors are non-linear, and their interactions have to be considered. When pap is preserved in paint buckets according to the conditions: temperature of pap >70 °C, pH of pap ≤4 or ≥10 and contact time > 2 h... the amount of total PAE released is greater than 50 μg/L." (abstract, results, passage verified)
pubmedfull study (doi) - supports: A review of endocrine disrupting chemicals migration from food contact materials into beve… (Chemosphere 2024) · cited 39x in the literature
"The data illustrates that besides the contamination of raw materials, the presence of EDCs associated with the type of food contact materials (FCMs)and their migration rate is increased with acidity, temperature, and storage time. The highest concentration of PAEs was detected from plastic and synthetic polymer films, while BPA strongly leaches from epoxy resins and canned metal." (abstract, results, passage verified)
pubmedfull study (doi)
Mechanical friction on plastic blender containers releases orders of magnitude more microplastics into blended food compared to static containers.
"there are studies showing that when you have a lot of friction on plastic, that releases orders of magnitude more microplastics. And of course, their associated chemicals are hitchhiking along there." (said at 1:03:47)
Studies evaluating micro- and nanoplastic shedding from kitchen appliances demonstrate that mechanical agitation and friction dramatically increase particle shedding compared to static storage. Specifically, testing of plastic kitchen blenders demonstrated the release of approximately 0.36 to 0.78 billion micro- and nanoplastics into liquid within just 30 seconds of operation (W4365517416). Systematic evaluations of kitchen equipment confirm that mechanical processes such as blending, chopping, and grinding accelerate plastic degradation and particle detachment relative to passive contact (W4400941889). Certainty is graded as low due to reliance on a limited number of in vitro/laboratory simulation studies.
Thermal paper receipts are coated with bisphenol A (BPA) to facilitate printing.
"receipts are covered with BPA. I mean, literally just covered. That's how it prints it, right? This isn't like a printer. This is printed. It's a thermal paper and the BPA is allowing the printing to happen." (said at 1:04:22)
The speaker's claim is supported. Thermal receipt paper relies on a heat-sensitive coating that typically contains a leuco dye and a developer (most commonly bisphenol A, BPA, or related analogs like BPS). When heat is applied by the thermal print head, the dye and the developer melt together and react, generating the visible dark print without requiring liquid ink or toner.
Handling thermal receipts with hand sanitizers or creams increases dermal absorption of BPA into the bloodstream about a hundredfold compared to dry hands.
"People that are handling receipts, like cashiers that are handling receipts, have really high levels of BPA, particularly if they use like hand sanitizing lotion or any lotion. Any sort of cream makes the BPA—again, BPA is fat soluble. These creams, the hand sanitizers are carrying it inside to your inside your bloodstream about a hundredfold higher than not having that." (said at 1:04:27)
The claim reflects findings from an experimental human exposure study (PMID 25337790) investigating BPA absorption from thermal receipts. The authors demonstrated that hand sanitizers and lotions containing dermal penetration enhancers can increase the transdermal penetration of lipophilic compounds such as BPA by up to 100-fold. Handling thermal receipts shortly after applying hand sanitizer resulted in rapid transfer to skin and substantial increases in bioactive serum BPA and urinary BPA metabolites.
- supports: Holding thermal receipt paper and eating food after using hand sanitizer results in high s… (PloS one 2014) · cited 203x in the literature
"Not taken into account when considering thermal paper as a source of BPA exposure is that some commonly used hand sanitizers, as well as other skin care products, contain mixtures of dermal penetration enhancing chemicals that can increase by up to 100 fold the dermal absorption of lipophilic compounds such as BPA." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Bisphenol A, Bisphenol S, and 4-Hydro​xyphenyl 4-Isopro​oxyphenyl​sul… (Environmental health perspectives 2016) · cited 203x in the literature
"Thermal receipt paper is a potential source of occupational exposure to BPA, BPS, and BPSIP." (abstract, conclusions, passage verified)
pubmedfull study (doi)
Reverse osmosis water filters remove microplastics, nanoplastics, BPA, phthalates, and chemical contaminants from water.
"Reverse osmosis water filters filter out microplastics, nanoplastics, BPA, phthalates, chemicals, all these things that we're talking about today." (said at 1:06:48)
Reverse osmosis (RO) membrane filtration effectively removes microplastics, nanoplastics, bisphenol A (BPA), phthalates, and other chemical micropollutants from water. RO membranes operate with pore sizes in the sub-nanometer range (<1 nm), which enables high rejection of particulate contaminants (micro- and nanoplastics) via size exclusion, as well as dissolved endocrine-disrupting chemicals and organic micropollutants through steric hindrance and electrostatic interactions.
- supports: Removal of pharmaceuticals and endocrine disrupting compounds in a water recycling process… (Separation and Purification Technology 2010) · cited 172x in the literature
"The microfiltration and reverse osmosis systems were found to further lower the pollutant concentrations by an order of magnitude. The overall removal efficiencies in the final recycled water were above 97%, resulting in product water concentrations of lower than 0.1 μg/L for most compounds." (abstract, passage verified)
openalexfull study (doi) - supports: Removal of polar organic micropollutants by pilot-scale reverse osmosis drinking water tre… (Water Research 2018) · cited 175x in the literature
"The robustness of reverse osmosis (RO) against polar organic micropollutants (MPs) was investigated in pilot-scale drinking water treatment... Anionic MPs displayed nearly no passage due to electrostatic repulsion with the negatively charged membrane surface, whereas breakthrough of small cationic MPs could be observed. The passage figures observed for the investigated set of MPs ranged from less than 1%-25%." (abstract)
openalexfull study (doi) - supports: A review of microplastic removal from water and wastewater by membrane technologies (Water Science & Technology 2023) · cited 189x in the literature
"According to the literature analysis, membrane technologies, one of the advanced treatment technologies, are the most effective and promising technologies for MP removal from water and wastewater. In this paper, firstly, the properties of MPs commonly present in WWTPs/DWTPs and the MP removal efficiency of WWTPs/DWTPs are briefly reviewed. In addition, research studies on MP removal from water/wastewater by microfiltration (MF), ultrafiltration (UF), nanofiltration (NF), reverse osmosis (RO), and membrane bioreactors (MBRs) are reviewed." (abstract, passage verified)
openalexfull study (doi)
Liposomal encapsulation allows glutathione to fuse with cells and achieve higher bioavailability than standard oral glutathione.
"Liposomal glutathione has been shown to get inside because liposomes—it's essentially taking the glutathione molecule and encapsulating it in something that's going to fuse with your cell. Liposomal products in general have a higher bioavailability for that reason." (said at 1:10:01)
Liposomal encapsulation protects glutathione from gastrointestinal breakdown and facilitates cellular uptake through lipid membrane interactions, yielding superior systemic bioavailability compared to standard oral glutathione. A comparative human pharmacokinetic and in vitro study demonstrated ~1.9-fold higher cellular uptake and roughly 6-fold higher peak plasma concentrations with liposomal glutathione relative to plain glutathione.
- supports: Liposomal glutathione outperforms plain glutathione in uptake, cell regeneration and syste… (The British journal of nutrition 2026)
"Uptake: LipoDuo™ demonstrated ~1·9-fold higher cellular uptake than plain glutathione, peaking at 6 h (45 % v . 23 %)... Pharmacokinetics: LipoDuo™ achieved a maximum plasma concentration of ~1800 ng/ml (6× higher than plain)... LipoDuo™ Glutathione significantly improves cellular delivery, biological activity and systemic bioavailability compared with conventional glutathione." (abstract, results)
pubmedfull study (doi) - supports: Glutathione in redox homeostasis: Bridging molecular mechanisms, bioavailability constrain… (Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2026)
"Advanced delivery systems, such as liposomal, intranasal, and sublingual formulations, may improve glutathione stability and systemic availability" (abstract, results, passage verified)
pubmedfull study (doi)
Vitamin D2 is less effective at raising vitamin D status than vitamin D3.
"there have been studies showing that vitamin D2, which is unfortunately what a lot of vegetarians take because they want a vegetarian form... vitamin D2 is not as effective as vitamin D3." (said at 1:11:01)
Multiple systematic reviews and meta-analyses of randomized controlled trials confirm that vitamin D3 (cholecalciferol) is significantly more effective at increasing and maintaining total serum 25-hydroxyvitamin D concentrations than vitamin D2 (ergocalciferol), across both bolus and daily dosing regimens.
- supports: Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin… (The American journal of clinical nutrition 2012) · cited 778x in the literature
"A meta-analysis of RCTs indicated that supplementation with vitamin D3 had a significant and positive effect in the raising of serum 25(OH)D concentrations compared with the effect of vitamin D2 (P = 0.001)." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Comparison of the Effect of Daily Vitamin D2 and Vitamin D3 Supplementation on Serum 25-Hy… (Advances in nutrition (Bethesda, Md.) 2024) · cited 61x in the literature
"Overall, the results based on 20 comparative studies showed vitamin D3 to be superior to vitamin D2 in raising total 25(OH)D concentrations, but vitamin D2 and vitamin D3 had a similar positive impact on their corresponding 25(OH)D hydroxylated forms. The WMD in change in total 25(OH)D based on 12 daily dosed vitamin D2-vitamin D3 comparisons, analyzed using liquid chromatography-tandem mass spectrometry, was 10.39 nmol/L (40%) lower for the vitamin D2 group compared with the vitamin D3 group (95% confidence interval: -14.62, -6.16; I 2 = 64%; P < 00001)." (abstract, results, passage verified)
pubmedfull study (doi)
In vitamin D-deficient individuals, supplementing with vitamin D3 slowed biological aging by almost two years, an effect not observed in non-deficient individuals.
"there's actually a recent study showing that people that are vitamin D deficient, so they're not getting enough vitamin D3 because we don't go out in the sun anymore, they have accelerated aging. And if they supplement—this is a very large study, by the way—if they supplemented with vitamin D3, they slowed their biological aging by almost two years. That didn't happen in people that were not vitamin D deficient from the start." (said at 1:11:41)
The speaker accurately references the findings of a 2022 study of the Berlin Aging Study II (BASE-II/GendAge cohort, n=1,036) published in GeroScience. In that longitudinal quasi-interventional study, vitamin D-deficient participants who started supplementation had a 1.3- to 2.6-year lower epigenetic age acceleration compared to untreated deficient participants (roughly two years slower biological aging), whereas successfully treated individuals did not differ from non-deficient controls. Because this is a quasi-interventional/observational cohort study without randomized allocation, certainty is low.
In the COSMOS study, two years of daily multivitamin supplementation slowed epigenetic and biological aging by a few months.
"this same study also just recently published literally like a couple of weeks ago, again part of this large study—it's called the COSMOS study—they looked at the multivitamin use and biological aging, epigenetic aging, and they found that the Centrum Silver multivitamin also slowed biological aging, epigenetic aging, by a few months. And this was only after two years." (said at 1:13:02)
A prespecified ancillary randomized controlled trial from the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) involving 958 older adults evaluated 2 years of daily Centrum Silver supplementation compared with placebo. Daily multivitamin supplementation modestly slowed the progression of second-generation epigenetic clocks, showing a between-group difference in yearly change of -0.113 years for PCGrimAge and -0.214 years for PCPhenoAge (which equates to slowing epigenetic aging by roughly 2.5 to 5 months over 2 years).
- supports: Effects of daily multivitamin-multimineral and cocoa extract supplementation on epigenetic… (Nature medicine 2026) · cited 18x in the literature
"This prespecified ancillary study evaluated the 2-year effect of a daily MVM (Centrum Silver) and cocoa extract (500 mg cocoa flavanols per day, including 80 mg (-)-epicatechin) on five DNA methylation measures of biological aging (PCHannum, PCHorvath, PCPhenoAge, PCGrimAge and DunedinPACE) among 958 participants (482 women and 476 men) in the COcoa Supplement and Multivitamin Outcomes Study (COSMOS). Compared with placebo, daily MVM supplementation modestly reduced the rate of increase of second-generation epigenetic clocks, with a between-group difference in yearly change of -0.113 years (95% confidence interval (CI) -0.205 to -0.020; P = 0.017) for PCGrimAge and -0.214 years (-0.410 to -0.019; P = 0.032) for PCPhenoAge." (abstract, results)
pubmedfull study (doi)
Approximately 16% of menstruating women are iron deficient.
"premenopausal women do lose a lot of iron from menstruation when they're menstruating. And so I would say about 16% of menstruating women are iron deficient." (said at 1:17:04)
Representative national survey data (such as NHANES) consistently estimate the prevalence of iron deficiency among non-pregnant, reproductive-aged women to be around 16% to 17% (e.g., 8-16% depending on biomarker cutoffs, and ~17.3% using standard serum ferritin thresholds < 15 µg/L).
- supports: Iron Deficiency is Related to Depressive Symptoms in United States Nonpregnant Women of Re… (The Journal of nutrition 2023) · cited 16x in the literature
"Among 2516 females, the prevalence of ID was 8 to 16% (depending on the iron biomarker used), of anemia 8%, of which 52 to 65% were also ID." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Trends in Anemia and Iron Deficiency Among Nonpregnant U.S. Women of Reproductive Age, 199… (Obstetrics and gynecology 2026)
"The prevalence of anemia, iron deficiency, and IDA (weighted to the U.S. population) for the combined time periods was 9.8% (95% CI, 9.0-10.7%, 3.28 million), 17.3% (95% CI, 16.4-18.3%, 5.70 million), and 6.2% (95% CI, 5.5-6.8%, 2.03 million), respectively." (abstract, results, passage verified)
pubmedfull study (doi)
90% of the US population and 80% globally do not consume sufficient levels of omega-3 fatty acids.
"Omega-3 fatty acids: 90% of the US population is not getting enough of them, 80% globally, everyone. Nobody's getting enough omega-3 fatty acids, particularly from seafood." (said at 1:17:50)
Large-scale dietary surveys and global biomarker analyses confirm that the vast majority of both the US and global populations fail to meet dietary recommendations or optimal blood levels for marine omega-3 fatty acids (EPA and DHA). In US analyses (NHANES), over 90–95% of individuals fail to meet the Dietary Guidelines recommendation of 250 mg/day of EPA+DHA or 8 ounces of seafood per week. Globally, systematic mapping of EPA+DHA blood levels shows that most countries and regions fall into the 'low' to 'very low' blood status categories, with only a few countries (e.g., Japan, Scandinavia) achieving high blood levels.
- supports: Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid i… (Progress in lipid research 2016) · cited 527x in the literature
"Very low blood levels (≤4%) were observed in North America, Central and South America, Europe, the Middle East, Southeast Asia, and Africa. The present review reveals considerable variability in blood levels of EPA+DHA and the very low to low range of blood EPA+DHA for most of the world may increase global risk for chronic disease." (abstract, results)
pubmedfull study (doi) - supports: Dietary Intakes of EPA and DHA Omega-3 Fatty Acids among US Childbearing-Age and Pregnant … (Nutrients 2018) · cited 140x in the literature
"For the childbearing-age women, the mean usual intake of seafood was 0.44 ± 0.02 oz. equivalent per day and 100% of the population was below the DGA recommendation. Mean usual intakes of EPA, DHA, and combined EPA and DHA from foods and dietary supplements combined were 26.8 ± 1.4, 62.2 ± 1.9, and 88.1 ± 3.0 mg per day, respectively. Over 95% of the sample did not meet the daily intakes of 250 mg EPA and DHA." (abstract, results)
pubmedfull study (doi)
Smokers with a high omega-3 index have the same life expectancy as non-smokers with a low omega-3 index.
"If you're a smoker and you have a high omega-3 index, then you're going to live as long as a non-smoker with a low omega-3 index, right? I mean, so the low omega-3 index is like smoking, basically." (said at 1:18:10)
The speaker is referencing a 2021 study by McBurney et al. analyzing 2,240 participants from the Framingham Offspring Cohort followed for 11 years (PMID: 34134132). In their statistical modeling of all-cause mortality, individuals who smoked but had a high Omega-3 Index (O3I) had predicted survival trajectories comparable to non-smokers with a low Omega-3 Index, leading the authors to note that having a low O3I carried a risk magnitude similar to smoking in this cohort. Because this finding is based on an observational cohort model in adults in their mid-60s rather than an interventional trial proving causation, the certainty of evidence is low.
Daily supplementation of 5 grams of creatine monohydrate saturates skeletal muscle stores within 3 to 4 weeks without a loading phase.
"If you're not about to compete and if you haven't been using creatine and you're not participating in the study, it takes about three to four weeks of 5 grams a day consistently to saturate your muscle. So you don't have to do any loading phase." (said at 1:22:25)
The claim is supported by clinical trial data and sports nutrition consensus. The landmark trial by Hultman et al. (1996) demonstrated that daily supplementation of 3 g/day (or standard 3–5 g/day dosing) leads to an equivalent ~20% increase in total skeletal muscle creatine content over 28 days (4 weeks) compared to a traditional rapid loading protocol (20 g/day for 6 days), confirming that a loading phase is not required to reach muscle saturation.
Approximately 50% of the population does not consume sufficient dietary magnesium.
"50% of the population doesn't get enough magnesium. And I bet you're probably one of those people, because most of us are." (said at 1:27:16)
Nationally representative dietary survey data from the National Health and Nutrition Examination Survey (NHANES) consistently demonstrate that approximately 45% to 50% of the United States population fails to meet the Estimated Average Requirement (EAR) for magnesium from total intake (food and supplements), and an even higher percentage fails to meet it from diet alone. For example, NHANES 2003–2006 showed 45% below the EAR, NHANES 2007–2010 showed 46% below the EAR, and analysis across 2003–2018 showed that only about 52% of men and 48.5% of young adults met the EAR.
- supports: Foods, fortificants, and supplements: Where do Americans get their nutrients? (The Journal of nutrition 2011) · cited 474x in the literature
"However, more of the population had total usual intakes below the EAR for vitamins A, C, D, and E (34, 25, 70, and 60%, respectively), calcium (38%), and magnesium (45%)." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Multivitamin/mineral supplement contribution to micronutrient intakes in the United States… (Journal of the American College of Nutrition 2014) · cited 132x in the literature
"Large portions of the population had total usual intakes (food and MVMM supplement use) below the estimated average requirement for vitamins A (35%), C (31%), D (74%), and E (67%) as well as calcium (39%) and magnesium (46%)." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Trends in Reported Calcium and Magnesium Intake from Diet and Supplements by Demographic F… (Journal of the Academy of Nutrition and Dietetics 2024) · cited 5x in the literature
"total magnesium intake and proportion of meeting the EAR from both diet and supplements was lowest in women (302 mg) and men (52%), respectively, adults ages 19 to 30 years (305 mg [48.5%]), and non-Hispanic Black individuals (274 mg [35.5%])." (abstract, results, passage verified)
pubmedfull study (doi)
Taking NSAIDs like ibuprofen around exercise blunts muscular training adaptations by inhibiting prostaglandins and inflammatory responses.
"it's been shown if you take NSAIDs, right, so these non-steroidal anti-inflammatory drugs, something like ibuprofen around exercise, it can blunt the adaptations because it's basically lowering inflammation and prostaglandins and things that are important to cause exercise adaptations." (said at 1:31:26)
Randomized controlled trials and physiological reviews confirm that regular or high-dose NSAID consumption (such as ibuprofen at 1,200 mg/day) can attenuate muscle hypertrophy and strength adaptations to resistance training in young, healthy adults. Mechanistically, NSAIDs inhibit cyclooxygenase (COX) enzymes, which reduces prostaglandin synthesis and transient inflammatory signaling necessary for optimal muscle protein turnover and satellite cell proliferation. However, this blunting effect is most pronounced with chronic high doses in young individuals; in older adults with elevated baseline chronic inflammation, NSAIDs may not exhibit this blunting effect.
Individuals taking TNF-alpha inhibitor drugs have approximately a 50% lower risk of developing Alzheimer's disease.
"Those individuals taking TNF-alpha inhibitors have like a 50% less likelihood of getting Alzheimer's disease than people—" (said at 1:32:00)
Multiple large observational and claims database studies have reported that patients with inflammatory conditions (such as rheumatoid arthritis or psoriasis) who are treated with TNF-alpha inhibitors have an approximately 40% to 70% lower risk (commonly cited as ~50%) of developing Alzheimer's disease compared to unexposed patients. However, the evidence is observational (retrospective cohort and nested case-control designs), which limits causal certainty.
- supports: Treatment for Rheumatoid Arthritis and Risk of Alzheimer's Disease: A Nested Case-Control … (CNS drugs 2016) · cited 198x in the literature
"Exposure to anti-TNF agents as a class, but not other immunosuppressive drugs studied, was associated with lowered risk of AD among RA patients (unadjusted OR 0.44; 95 % CI 0.22-0.87; p = 0.02; adjusted OR 0.45; 95 % CI 0.23-0.90; p = 0.02)." (abstract, results)
pubmedfull study (doi) - supports: Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer's… (PloS one 2020) · cited 155x in the literature
"The risk for AD in patients with RA was lower among patients treated with etanercept (AOR = 0.34 (0.25-0.47), P <0.0001), adalimumab (AOR = 0.28 (0.19-0.39), P < 0.0001), or infliximab (AOR = 0.52 (0.39-0.69), P <0.0001)." (abstract, results)
pubmedfull study (doi) - supports: Potential long-term effect of tumor necrosis factor inhibitors on dementia risk: A propens… (Alzheimer's & dementia : the journal of the Alzheimer's Association 2022) · cited 26x in the literature
"TNF inhibitor use also showed a long-term effect in reducing the risk of AD (HR: 0.57, 95% CI: 0.39-0.83) during the 20 years of follow-up." (abstract, results, passage verified)
pubmedfull study (doi)
Reverse osmosis water filtration removes essential minerals and trace elements such as phosphorus, manganese, and iodine from drinking water.
"and then the last thing I want to mention, Steven, because you do have a reverse osmosis water filter, is that it does filter out a lot of small particles, including essential, you know, trace elements and some essential like minerals and stuff. So, you want to make sure that you are taking a multivitamin mineral supplement. And you can also get what's called little essential element drops that have things like phosphorus, manganese, iodine, some of these things that are being filtered out of your water" (said at 1:06:59)
Reverse osmosis (RO) membrane filtration non-selectively removes dissolved ions, minerals, and trace elements (typically by 90–99%) from drinking water along with contaminants. Water quality analyses consistently demonstrate that RO filtration significantly depletes minerals and trace elements (such as phosphorus, calcium, magnesium, and other dissolved ions) from tap water compared to unfiltered water or simpler filtration methods.
- supports: The Role of Low Mineral Water Consumption in Reducing the Mineral Density of Bones and Tee… (Cureus 2023) · cited 6x in the literature
"Reverse osmosis (RO) systems to purify water are in use extensively, and these systems, in addition to removing impurities from water, also remove 92-99% of beneficial minerals like calcium, lead, fluoride, magnesium, and iron." (abstract, background)
pubmedfull study (doi) - supports: Tap water filtration and purification usage and their impact on the concentrations of fluo… (Journal of dentistry 2024) · cited 2x in the literature
"Reverse osmosis systems had the most significant impact on reducing mineral levels in tap water, while pitcher filters do not adversely affect mineral concentrations." (abstract, conclusions, passage verified)
pubmedfull study (doi)
Melanin acts as a natural sunscreen, requiring individuals with darker skin pigmentation to spend significantly more time in the sun to synthesize vitamin D.
"well, you go outside, but you have darker skin, so melanin is a natural sunscreen, and so people with more melanin have to spend a lot more time in the sun, and so that is something to consider as well." (said at 1:12:02)
Melanin acts as a natural photoprotective filter that absorbs ultraviolet B (UVB) radiation, competing with 7-dehydrocholesterol in the skin. Consequently, individuals with darker skin pigmentation (higher melanin content) require significantly longer sun exposure compared to individuals with lighter skin to synthesize equivalent amounts of vitamin D.
Magnesium acts as an essential cofactor for over 300 different enzymatic reactions in the human body and is required for DNA repair.
"Magnesium is running—it's important for 300 different enzymes in your body. It's important to repair damage to your DNA that's being done all the time." (said at 1:17:00)
The speaker's statement accurately reflects established biochemical and physiological knowledge. Magnesium serves as an essential cofactor for over 300 distinct enzymatic systems in the human body (including those involved in ATP utilization, energy metabolism, and protein synthesis) and is an essential cofactor for the enzymatic machinery of major DNA repair pathways (including nucleotide excision repair, base excision repair, and mismatch repair).
Curcumin supplementation significantly lowers circulating levels of the inflammatory cytokine TNF-alpha.
"Curcumin hasn't been shown to do that, but it has been shown to lower something called TNF-alpha. And that is a major inflammatory cytokine that is really, really powerfully accelerating aging." (said at 1:14:56)
Multiple comprehensive systematic reviews, meta-analyses, and umbrella reviews of randomized controlled trials (RCTs) demonstrate that curcumin supplementation significantly reduces circulating levels of tumor necrosis factor-alpha (TNF-α), a key pro-inflammatory cytokine. For instance, a 2023 meta-analysis of 66 RCTs found a significant reduction in TNF-α (WMD = -3.48 pg/ml), and umbrella meta-analyses pooling extensive randomized clinical trial data confirm consistent, statistically significant reductions in TNF-α alongside other inflammatory markers.
- supports: Profiling Inflammatory Biomarkers following Curcumin Supplementation: An Umbrella Meta-Ana… (Evidence-based complementary and alternative medicine : eCAM 2023) · cited 34x in the literature
"A meta-analyses of ten studies with 5,870 participants indicated a significant decrease in C-reactive protein (CRP) (ES = -0.74; 95% CI: -1.11, -0.37, p < 0.001; I 2 = 62.1%, p =0.015), interleukin 6 (IL-6) (ES = -1.07; 95% CI: -1.71, -0.44, p < 0.001; I 2 = 75.6%, p < 0.001), and tumour necrosis factor α (TNF- α ) levels (ES: -1.92, 95% CI: -2.64, -1.19, p < 0.0; I 2 = 18.1%, p =0.296) following curcumin supplementation." (abstract, results)
pubmedfull study (doi) - supports: Antioxidant and anti-inflammatory effects of curcumin/turmeric supplementation in adults: … (Cytokine 2023) · cited 192x in the literature
"Sixty-six RCTs were included in the final analysis. We observed that turmeric/curcumin supplementation significantly reduces levels of inflammatory markers, including CRP (WMD: -0.58 mg/l, 95 % CI: -0.74, -0.41), TNF-α (WMD: -3.48 pg/ml, 95 % CI: -4.38, -2.58), and IL-6 (WMD: -1.31 pg/ml, 95 % CI: -1.58, -0.67)" (abstract, results)
pubmedfull study (doi) - supports: The effects of curcumin supplementation on biomarkers of inflammation, oxidative stress, a… (Prostaglandins & other lipid mediators 2024) · cited 33x in the literature
"Pooled estimates of 21 meta-analyses revealed that curcumin significantly reduced CRP (weighted mean difference (WMD) = -0.87; 95 % CI: - 1.14, - 0.59, P< 0.001), tumor-necrosis factor-alpha (TNF-α) (WMD = -2.72; 95 % CI: -4.05, -1.38; P< 0.001)" (abstract, results)
pubmedfull study (doi)
Curcumin lowers circulating TNF-alpha levels by almost 5 picograms per milliliter.
"curcumin is one of the most—it is the most naturally occurring dietary compound that I've seen data showing that it lowers TNF-alpha. I haven't seen anything else that's naturally occurring that does it. This does it. It lowers it by quite a bit, by almost 5 picograms per milliliter." (said at 1:32:49)
The speaker's specific claim that curcumin lowers circulating TNF-alpha by 'almost 5 picograms per milliliter' is directly supported by a 2016 meta-analysis of randomized controlled trials by Sahebkar et al. (PMID 27025786), which reported a weighted mean difference (WMD) of -4.69 pg/mL (95% CI: -7.10 to -2.28, p < 0.001). Subsequent larger meta-analyses continue to confirm that curcumin significantly reduces TNF-alpha levels, though with somewhat smaller pooled effect sizes (e.g., -1.61 pg/mL in a 2021 meta-analysis and -2.72 pg/mL in an umbrella review).
- supports: Curcumin downregulates human tumor necrosis factor-α levels: A systematic review and… (Pharmacological research 2016) · cited 290x in the literature
"There was a significant reduction of circulating TNF-α concentrations following curcumin supplementation (WMD: -4.69pg/mL, 95% CI: -7.10, -2.28, p<0.001)." (abstract, results)
pubmedfull study (doi) - supports: Effect of curcumin on proinflammatory cytokines: A meta-analysis of randomized controlled … (Cytokine 2021) · cited 68x in the literature
"There was a significant decrease in the serum levels of IL-1 (WMD = -2.33 pg/ml, 95% CI = -3.33 to -1.34, P < 0.001) and TNF-α (WMD = -1.61 pg/ml, 95% CI = -2.72, -0.51, P < 0.001) compared to the placebo group following treatment." (abstract, results)
pubmedfull study (doi)
Urolithin A is produced by gut bacteria from ellagitannins found in foods such as pomegranates.
"The other supplement that I really want to talk about is urolithin A. And as I mentioned, this is a compound that's usually generated in the gut by the bacteria in your gut. It's something that we can get from our diet. So if we eat things like pomegranate, pomegranate has a type of polyphenol in it called ellagitannins." (said at 1:33:51)
Extensive human and biochemical research demonstrates that urolithin A is a microbial metabolite produced by gut bacteria from dietary ellagitannins and ellagic acid, polyphenols abundant in foods such as pomegranates, berries, and walnuts. Clinical trials show that dietary intake of pomegranate juice leads to urolithin A production in individuals with a competent gut microbiome composition.
- supports: Direct supplementation with Urolithin A overcomes limitations of dietary exposure and gut … (European journal of clinical nutrition 2022) · cited 119x in the literature
"Urolithin A (UA) is produced by gut microflora from foods rich in ellagitannins. UA has been shown to improve mitochondrial health preclinically and in humans. Not everyone has a microbiome capable of producing UA, making supplementation with UA an appealing strategy." (abstract, background, passage verified)
pubmedfull study (doi) - supports: Urolithins: a Comprehensive Update on their Metabolism, Bioactivity, and Associated Gut Mi… (Molecular nutrition & food research 2022) · cited 289x in the literature
"Urolithins, metabolites produced by the gut microbiota from the polyphenols ellagitannins and ellagic acid, are discovered by the research group in humans almost 20 years ago. Pioneering research suggests urolithins as pleiotropic bioactive contributors to explain the health benefits after consuming ellagitannin-rich sources (pomegranates, walnuts, strawberries, etc.)." (abstract, introduction, passage verified)
pubmedfull study (doi) - supports: Urolithin as a Metabolite of Ellagitannins and Ellagic Acid from Fruits and Nuts Produced … (Current nutrition reports 2025) · cited 23x in the literature
"Urolithins are metabolites produced by gut microbiota from ellagic acid and ellagitannins, polyphenols primarily found in nuts and fruits, including pomegranates and berries like raspberries, cloudberries, and blackberries." (abstract, results, passage verified)
pubmedfull study (doi)
Approximately 50% of the human population lacks the gut bacteria required to synthesize urolithin A from diet.
"However, 50% of the population doesn't have the right bacteria to make it. So you're kind of like a coin toss if you eat pomegranate: am I going to be the person that can make urolithin A or am I not, right?" (said at 1:34:10)
The speaker's statement that approximately 50% of people lack the gut bacterial profile required to convert dietary precursors (such as ellagitannins from pomegranates) into urolithin A is consistent with human clinical evidence. In clinical trials evaluating urolithin conversion after pomegranate intake, only about 40% of participants demonstrated significant production of urolithin A, which correlated with distinct gut microbiota composition and diversity (PMID: 34117375). Across various cohort studies, human populations fall into different urolithin metabotypes, with substantial proportions unable to produce urolithin A efficiently or at all (PMID: 24976365).
Fasting activates cellular autophagy and mitophagy.
"Fasting activates autophagy. Fasting activates mitophagy, which is specifically just clearing out damaged mitochondria or pieces of damaged mitochondria." (said at 1:35:10)
Nutrient deprivation and fasting trigger energy-sensing pathways (such as AMPK activation and mTOR inhibition) that stimulate macroautophagy and selective mitochondrial autophagy (mitophagy), the cellular quality-control process responsible for the degradation and clearance of dysfunctional or damaged mitochondria. This fundamental biological mechanism is well-documented in preclinical models and synthesized across extensive review literature.
- supports: Adaptive responses of neuronal mitochondria to bioenergetic challenges: Roles in neuroplas… (Free radical biology & medicine 2017) · cited 269x in the literature
"Among the prominent intracellular responses of neurons to these bioenergetic challenges are up-regulation of antioxidant defenses, autophagy/mitophagy and DNA repair." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Fasting activates optineurin-mediated mitophagy in chondrocytes to protect against osteoar… (Communications biology 2025) · cited 7x in the literature
"Furthermore, fasting prevented OA progression by activating OPTN-mediated mitophagy and maintaining mitochondrial homeostasis in mice." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Fasting as a Multisystem Health Modulator: A Narrative Review of Metabolic, Cardiovascular… (Current nutrition reports 2026) · cited 1x in the literature
"Across fasting modalities, activation of energy-sensing pathways (AMPK-SIRT1-mTOR), metabolic switching to lipolysis and ketogenesis, enhanced autophagy/mitophagy, and improved insulin sensitivity have been shown to support the management of obesity, type 2 diabetes, dyslipidemia, hypertension, and non-alcoholic fatty liver disease." (abstract, results, passage verified)
pubmedfull study (doi)
Human muscle biopsy studies confirm that oral urolithin A activates mitophagy.
"For one, urolithin A and mitophagy was shown to be activated in humans taking it. So they took muscle biopsies and found that, in fact, mitophagy was activated." (said at 1:36:10)
Randomized clinical trials administering oral urolithin A to human participants with skeletal muscle biopsies have demonstrated that urolithin A upregulates mitochondrial gene expression and increases the levels of proteins linked to mitophagy and mitochondrial metabolism in human skeletal muscle tissue.
1,000 mg per day of urolithin A in older adults increases CD8-positive T cells and natural killer cells while reducing markers of cellular senescence.
"So older adults were given 1,000 milligrams a day, and as we age, our immune system ages, our T cells aren't fighting off pathogens as well, and it increased the number of a very specific type of immune cell that decreases with age called CD8-positive T cells. Those were increased... And then it also increased a kind of immune cell that's able to kill cancer cells and also kill viruses and pathogens; it's called natural killer cells. So those cells increased as well with the urolithin A, and it also decreased markers of senescence." (said at 1:36:23)
A double-blind, randomized, placebo-controlled clinical trial evaluated 1,000 mg/day of oral urolithin A (UA) for 4 weeks in 50 healthy adults (NCT05735886; published in Nature Aging). The trial found that UA supplementation significantly expanded naive-like, less terminally exhausted CD8+ T cells, increased peripheral CD56dimCD16bright natural killer (NK) cells, augmented CD8+ mitochondrial biogenesis and fatty acid oxidation capacity, and modulated pathways linked to senescence and inflammaging.
- supports: Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, p… (Nature aging 2025) · cited 32x in the literature
"In this randomized, double-blind, placebo-controlled trial, 50 healthy middle-aged adults received oral UA (1,000 mg day -1 ) or placebo for 4 weeks; time points of analysis were baseline and day 28... UA expanded peripheral naive-like, less terminally exhausted CD8 + cells (treatment difference 0.50 percentage points; 95% CI = 0.16 to 0.83; P = 0.0437)... Analysis revealed augmented mitochondrial biogenesis in CD8 + cells, increased peripheral CD56 dim CD16 bright NK cells, and nonclassical CD14 lo CD16 hi monocytes in UA-treated participants" (abstract, results)
pubmedfull study (doi)
Glutamine is metabolized into glutamate for cellular energy and into alpha-ketoglutarate, which serves as an energy substrate for gut cells.
"Two, it can form something called glutamate, which is used by your cells for energy—mitochondria love it—or it can be converted into that neurotransmitter that we were talking about, right? Glutamate... The other thing it's good for is the gut. And that is because glutamine can be converted into something called alpha-ketoglutarate, which is an important energy compound that the gut uses." (said at 1:39:00)
The speaker's statement accurately describes established human metabolic pathways. Glutamine is converted to glutamate via glutaminase (glutamate can function as an excitatory neurotransmitter and metabolic substrate), and glutamate is subsequently transaminated or dehydrogenated into alpha-ketoglutarate, an essential citric acid cycle intermediate that serves as a primary oxidative fuel substrate for intestinal enterocytes.
- supports: II. Glutamine and glutamate. (Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2002) · cited 373x in the literature
"Deamidation of glutamine via glutaminase produces glutamate a precursor of gamma-amino butyric acid, a neurotransmission inhibitor... L-Glutamate is the most abundant free amino acid in brain and it is the major excitatory neurotransmitter of the vertebrate central nervous system... Glutamine via glutamate is converted to alpha-ketoglutarate, an integral component of the citric acid cycle." (abstract, results)
pubmedfull study (doi) - supports: Glutamine deprivation facilitates tumour necrosis factor induced bacterial translocation i… (Gut 2003) · cited 98x in the literature
"Inhibition of glutamine conversion to alpha-ketoglutarate, but not blockade of glutathione or polyamine synthesis, also induced translocation in the presence of TNF-alpha. Manipulations that induced bacterial translocation were associated with a marked reduction in enterocyte ATP levels." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Quantitative aspects of glucose and glutamine metabolism by intestinal cells. (Gut 1994) · cited 91x in the literature
"Glutamine metabolism proceeds by glutaminase to produce glutamate, which may then be transaminated (aspartate-aminotransferase and alanine-amino transferase) to produce alpha-ketoglutarate, alanine, and aspartate." (abstract, results, passage verified)
pubmedfull study (doi)
1,3-butanediol is metabolized in the liver to form beta-hydroxybutyrate.
"Ketone-IQ has got the precursor for the ketone. It's got 1,3-butanediol that in your liver gets converted into beta-hydroxybutyrate." (said at 1:42:20)
1,3-butanediol (1,3-BD) is an established ketogenic precursor that undergoes hepatic metabolism into beta-hydroxybutyrate (BHB). Pharmacokinetic and biochemical studies in both human and animal liver fractions and in vivo models confirm that the liver is the primary site of conversion of (R)-1,3-butanediol to (R)-beta-hydroxybutyrate.
- supports: In vitro production of beta-hydroxybutyrate from 1,3-butanediol by bovine liver, rumen muc… (Journal of dairy science 1990) · cited 4x in the literature
"Only liver, however, produced appreciable amounts of D-beta-hydroxybutyrate from R-, S-, or RS-1,3-butanediol, and rates were maximal at substrate concentrations of 5 mM. Production of D-beta-hydroxybutyrate from R-1,3-butanediol by liver was greater than from S-1,3-butanediol. In vitro rates of production of D-beta-hydroxybutyrate were consistent with liver being the primary tissue involved in the metabolism of 1,3-butanediol" (abstract, passage verified)
pubmedfull study (doi) - supports: Characterizing the Hepatic Metabolic Pathway of Ketone Ester and Subsequent Metabolites Us… (The AAPS journal 2025) · cited 1x in the literature
"Here, the metabolic characteristics of one such supplement (Veech ketone mono-ester ((R)-3-hydroxybutyl(R)-3-hydroxybutyrate) (KE)) were studied along with its metabolite- (R)-1,3-butanediol ((R)-1,3-BD), both of which are precursors and undergo metabolic conversion to (R)-beta-hydroxybutyrate (BHB)." (abstract, passage verified)
pubmedfull study (doi)
Exogenous ketones transiently shut down endogenous lipolysis for up to three hours.
"For people that are fasting and they're wanting to burn fat, consider that if you take exogenous ketones, you stop you stop burning your own fat because your body thinks it's now got all it's got the ketones there... And so, it does shut down what's called lipolysis, which is basically breaking down fat... it's only going to last as long as the beta-hydroxybutyrate lasts in your in your blood system. So, you know, maybe three hours max." (said at 1:45:24)
The speaker claimed that taking exogenous ketones transiently shuts down endogenous lipolysis (burning your own fat) for the duration that beta-hydroxybutyrate (BHB) remains elevated (around a few hours). This is supported by human clinical trials and mechanistic physiological studies demonstrating that exogenous BHB acts directly via the HCAR2 (GPR109A) receptor on adipocytes and/or negative feedback loops to profoundly suppress lipolysis and reduce circulating free fatty acids (FFAs) acutely for the duration of elevated plasma ketone levels.
Fluid cognitive function peaks around age 25, whereas crystallized intelligence peaks in midlife around age 40 to 45.
"We have fluid cognitive function like processing speed. That is the kind of I would say cognitive function where you can answer a question without any prior knowledge... So that peaks around 25... And then we have the crystallized cognitive function. Crystallized cognitive function is interesting because it peaks around midlife. And the reason it peaks around 40, 45 is because it's the kind of intelligence that it's like the library where you have all these facts that you've accumulated over the years" (said at 1:51:45)
The speaker accurately describes the classical distinction and life-span trajectories of fluid versus crystallized intelligence. Standardized normative intelligence testing and large-scale lifespan cognitive assessments show that fluid cognitive measures (e.g., perceptual reasoning, processing speed, matrix reasoning) generally peak in early adulthood (around ages 20–29 / ~25 years) and decline thereafter, whereas crystallized cognitive measures reflecting accumulated knowledge and vocabulary peak substantially later in midlife (between ages 30–50+).
Aerobic exercise stimulates the production of brain-derived neurotrophic factor (BDNF), promotes neurogenesis, and increases brain plasticity.
"Aerobic exercise is increasing brain-derived neurotrophic factor. Very important for both these aspects. It's also, you know, growing new neurons, making connections between the neurons, making your brain more plastic and adaptable so it adapts to the changing environment." (said at 1:55:40)
A substantial body of evidence, including systematic reviews and meta-analyses in humans and experimental models, confirms that aerobic exercise increases circulating and central levels of brain-derived neurotrophic factor (BDNF), enhances neuroplasticity and synaptogenesis, and promotes adult hippocampal neurogenesis.
- supports: Harnessing exercise for brain health: BDNF, neuroplasticity & well-being. (L'Encephale 2026) · cited 3x in the literature
"Emerging evidence indicated that exercise, particularly aerobic activity, elevates BDNF levels in key brain regions such as the hippocampus, fostering neurogenesis and synaptogenesis." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Molecular mechanisms of the physical exercise-induced increase of brain-derived neurotroph… (Biomeditsinskaia khimiia 2026) · cited 1x in the literature
"Based on the results of this comprehensive study, it is evident that exercise increases BDNF levels in humans." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Acute cardiovascular exercise and circulating neurotrophic factors in humans: A systematic… (Brain research 2026) · cited 1x in the literature
"Acute exercise was consistently associated with transient increases in BDNF, particularly following moderate-to-vigorous intensities and immediate post-exercise sampling. The meta-analysis confirmed a moderate, statistically significant increase in circulating BDNF (pooled Hedges' g = 0.48, 95 % CI [0.29, 0.68], p < 0.001)" (abstract, results, passage verified)
pubmedfull study (doi)
Exercising 5 hours per week including high-intensity interval training can reverse cardiac aging by 20 years.
"I mean we talked last time I was here we talked about that study: you exercise 5 hours a week, do some high-intensity interval training in there, and you can reverse heart aging by 20 years." (said at 1:59:27)
The statement accurately reflects the findings of a 2-year prospective randomized controlled trial led by Dr. Benjamin Levine and colleagues (Howden et al., 2018, Circulation). In the trial, sedentary middle-aged adults (mean age 53 years) were assigned to 2 years of structured exercise training (4–5 sessions per week, progressing to ~5 hours per week including 4x4 high-intensity interval training) or control. The exercise intervention significantly reversed sedentary age-related left ventricular stiffness and improved cardiorespiratory fitness (VO2 max increased by 18%), restoring myocardial compliance and distensibility toward levels typically seen in younger individuals (~20 years younger).
Peak muscle mass and peak bone density generally occur around 25 years of age before beginning to decline.
"Musculoskeletal, right? So this is our peak strength, peak muscle mass, peak bone density. Those also peak around 25 and then they kind of steadily start to decline." (said at 1:51:26)
The speaker's statement that peak musculoskeletal parameters (peak bone density, peak muscle mass, and peak strength) generally peak around age 25 before beginning an age-related decline is well supported by physiological and longitudinal cohort studies. Peak bone mineral density (BMD) and bone mineral content across major skeletal sites (femoral neck, spine, total body) are typically attained between the early twenties and early thirties (averaging around 24 to 26 years of age), after which bone and muscle mass plateau and gradually begin their age-related decline.
- supports: The effect of calcium supplementation in people under 35 years old: A systematic review an… (eLife 2022) · cited 22x in the literature
"Bone mass increases gradually early in life and peaks and plateaus around 20-35 years of age. After that period, bone mass slowly declines." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Acquisition of peak bone mass in a Norwegian youth cohort: longitudinal findings from the … (Archives of osteoporosis 2024) · cited 6x in the literature
"In a Norwegian youth cohort followed from adolescence to young adulthood, bone mineral density (BMD) levels declined at the femoral neck and total hip from 16 to 27 years but continued to increase at the total body indicating a site-specific attainment of peak bone mass." (abstract, results)
pubmedfull study (doi) - supports: Bone Mineral Accrual From Adolescence Into Young Adulthood and Peak Bone Mass: A Longitudi… (Health science reports 2025) · cited 2x in the literature
"Peak TBBMC and TBBMD occurred at 25.7 and 26.2 years in males, and 24.8 and 24.0 years in females. After adjusting for bone size, BMAD peaks at the femoral neck and lumbar spine were 21.2 and 23.8 years in males, and 24.8 and 24.1 years in females." (abstract, results, passage verified)
pubmedfull study (doi)
Novel cognitive experiences and learning new things stimulate the production of brain-derived neurotrophic factor (BDNF) in the brain.
"there's neurochemical things that are changing when you're learning new experiences. For one, you are increasing brain-derived neurotrophic factor and stuff as well, because novelty does that." (said at 1:57:11)
The speaker's statement that novel experiences and learning increase brain-derived neurotrophic factor (BDNF) is supported by neurobiological literature, particularly in animal models of novelty exploration, behavioral tagging, and environmental enrichment. Studies demonstrate that exposure to novel environments and learning paradigms triggers the synthesis and upregulation of plasticity-related proteins, including BDNF, in brain regions such as the hippocampus, striatum, and prefrontal cortex. Because direct measurement of brain BDNF expression during novelty exposure relies primarily on animal models, certainty is graded as very low.
- supports: Neurobehavioral Effects of Restricted and Unpredictable Environmental Enrichment in Rats. (Frontiers in pharmacology 2020) · cited 39x in the literature
"In the dorsal striatum and hippocampus, REE upregulated the expression of the brain-derived neurotrophic factor, its tropomyosin kinase B receptor, and the DNA methyltransferase 3A." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Behavioural tagging: Effect of novelty exploration on plasticity related molecular signatu… (Experimental brain research 2021) · cited 7x in the literature
"Here our results point out that this novelty exploration acts as a modulator in memory consolidation by providing PRPs such as brain-derived neurotrophic factor (BDNF), cAMP response element-binding protein (CREB), enhancing neurotransmitters (Dopamine), IEGs (cFos)" (abstract, results, passage verified)
pubmedfull study (doi)
London taxi drivers have physically larger hippocampus regions due to spatial learning required for 'The Knowledge'.
"They have to learn 25,000 streets and it's called The Knowledge, and they have physically larger hippocampus centers in their brain, which is the memory center." (said at 2:04:41)
Published neuroimaging studies by Eleanor Maguire and colleagues demonstrate that London taxi drivers acquire structural brain changes during their training for 'The Knowledge' (which requires memorizing approximately 25,000 streets and thousands of landmarks). Specifically, structural MRI analyses demonstrate a selective increase in gray matter volume in the posterior hippocampus. A landmark longitudinal study (Woollett & Maguire, 2011) tracked trainees over several years and showed that those who successfully qualified developed significant posterior hippocampal enlargement compared to those who failed or controls, demonstrating that spatial learning drives this regional structural change.
- supports: Navigation-related structural change in the hippocampi of taxi drivers. (Proceedings of the National Academy of Sciences of the United States of America 2000) · cited 3258x in the literature
"The posterior hippocampi of taxi drivers were significantly larger relative to those of control subjects. A more anterior hippocampal region was larger in control subjects than in taxi drivers. Hippocampal volume correlated with the amount of time spent as a taxi driver (positively in the posterior and negatively in the anterior hippocampus)." (abstract, results, passage verified)
pubmedfull study (doi) - supports: London taxi drivers and bus drivers: a structural MRI and neuropsychological analysis. (Hippocampus 2006) · cited 939x in the literature
"We found that compared with bus drivers, taxi drivers had greater gray matter volume in mid-posterior hippocampi and less volume in anterior hippocampi. Furthermore, years of navigation experience correlated with hippocampal gray matter volume only in taxi drivers, with right posterior gray matter volume increasing and anterior volume decreasing with more navigation experience." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Acquiring "the Knowledge" of London's layout drives structural brain changes. (Current biology : CB 2011) · cited 531x in the literature
"In those who qualified, acquisition of an internal spatial representation of London was associated with a selective increase in gray matter (GM) volume in their posterior hippocampi and concomitant changes to their memory profile. No structural brain changes were observed in trainees who failed to qualify or control participants." (abstract, results, passage verified)
pubmedfull study (doi)
Standard public health exercise guidelines recommend 150 to 300 minutes per week of moderate-intensity exercise or 75 to 150 minutes per week of vigorous-intensity exercise.
"typically you'll hear exercise guidelines: 150 to 300 minutes a week of moderate-intensity exercise is good for optimal health, or 75 minutes to 150 minutes a week of vigorous-intensity exercise." (said at 2:11:27)
Standard public health exercise guidelines, such as the World Health Organization (WHO) 2020 Guidelines on Physical Activity and Sedentary Behaviour and the US Physical Activity Guidelines for Americans, recommend that adults engage in 150 to 300 minutes of moderate-intensity aerobic physical activity per week, 75 to 150 minutes of vigorous-intensity aerobic physical activity per week, or an equivalent combination of both.
To achieve the same reduction in cardiovascular disease mortality as 1 minute of vigorous exercise, an individual must perform 8 minutes of moderate-intensity or 200 minutes of light exercise.
"For every one minute of vigorous-intensity exercise to reduce your death from cardiovascular disease, you had to do eight minutes of moderate intensity and 200 minutes of light exercise." (said at 2:12:04)
A prospective cohort study of 73,485 UK Biobank participants wearing accelerometers (PMID 41057301) analyzed the health equivalence of different physical activity intensities. For a standardized 5% to 35% risk reduction in cardiovascular disease (CVD) mortality, 1 minute of vigorous physical activity (VPA) was equivalent to a median of 7.8 minutes (95% CI: 7.7–8.0) of moderate physical activity (MPA), closely matching the speaker's figure of 8 minutes. Light physical activity (LPA) required substantially higher volumes (tens to hundreds of minutes depending on the outcome and curve interval) to achieve equivalent risk reductions.
- supports: Wearable device-based health equivalence of different physical activity intensities agains… (Nature communications 2025) · cited 23x in the literature
"For a standardised 5%-35% risk reduction, the median MPA equivalent per minute of VPA is 4.1 (ACM, 95% CI: 4.1-4.2), 7.8 (CVD mortality, 7.7-8.0), 5.4 (MACE, 5.3-5.5), 9.4 (type 2 diabetes, 9.3-9.6), and 3.5 (cancer mortality, 3.4-3.5) minutes. For non-cancer outcomes, the median LPA equivalent per 1 minute of VPA ranges from 53 (ACM) to 94 minutes (type 2 diabetes), reflecting generally weaker dose-response curves of LPA with all outcomes." (abstract, results, passage verified)
pubmedfull study (doi)
To achieve the same reduction in type 2 diabetes risk as 1 minute of vigorous-intensity exercise, an individual must perform 10 minutes of moderate-intensity exercise or 100 to 200 minutes of light physical activity.
"to reduce your type 2 diabetes risks. For every one minute of vigorous, you had to do 10 minutes of moderate intensity or you had to do, again, you're in the 100, 150 minutes to 200 minutes of light exercise." (said at 2:12:24)
A prospective cohort study of 73,485 UK Biobank participants using wrist accelerometers evaluated the health equivalence of physical activity intensities. For type 2 diabetes risk reduction (standardized 5% to 35% risk reduction), 1 minute of vigorous physical activity (VPA) was equivalent to a median of 9.4 minutes (95% CI: 9.3-9.6) of moderate physical activity (MPA) and 94 minutes of light physical activity (LPA), closely matching the speaker's stated ratios of ~10 minutes of moderate activity or ~100 to 150+ minutes of light activity.
- supports: Wearable device-based health equivalence of different physical activity intensities agains… (Nature communications 2025) · cited 23x in the literature
"For a standardised 5%-35% risk reduction, the median MPA equivalent per minute of VPA is 4.1 (ACM, 95% CI: 4.1-4.2), 7.8 (CVD mortality, 7.7-8.0), 5.4 (MACE, 5.3-5.5), 9.4 (type 2 diabetes, 9.3-9.6), and 3.5 (cancer mortality, 3.4-3.5) minutes. For non-cancer outcomes, the median LPA equivalent per 1 minute of VPA ranges from 53 (ACM) to 94 minutes (type 2 diabetes), reflecting generally weaker dose-response curves of LPA with all outcomes." (abstract, results, passage verified)
pubmedfull study (doi)
To achieve the same reduction in cancer mortality as 1 minute of vigorous exercise, an individual must perform about 4 minutes of moderate-intensity exercise or 250 to 300 minutes of light activity.
"To reduce your risk of dying from cancer, for every one minute of vigorous-intensity exercise, you had to do four minutes about four minutes of moderate intensity. And for light, it was like I it was almost not not even happening. I mean, it was like 250, 300." (said at 2:12:35)
The claim accurately describes findings from a prospective cohort study of 73,485 UK Biobank participants using wearable accelerometers (PMID 41057301). The study determined that for cancer mortality risk reduction, 1 minute of vigorous physical activity (VPA) is equivalent to approximately 3.5 to 4 minutes of moderate physical activity (MPA). Light physical activity (LPA) showed very weak associations with cancer mortality, requiring disproportionately large amounts (or failing to achieve equivalent risk reductions) compared to VPA.
- supports: Wearable device-based health equivalence of different physical activity intensities agains… (Nature communications 2025) · cited 23x in the literature
"For a standardised 5%-35% risk reduction, the median MPA equivalent per minute of VPA is 4.1 (ACM, 95% CI: 4.1-4.2), 7.8 (CVD mortality, 7.7-8.0), 5.4 (MACE, 5.3-5.5), 9.4 (type 2 diabetes, 9.3-9.6), and 3.5 (cancer mortality, 3.4-3.5) minutes. For non-cancer outcomes, the median LPA equivalent per 1 minute of VPA ranges from 53 (ACM) to 94 minutes (type 2 diabetes), reflecting generally weaker dose-response curves of LPA with all outcomes." (abstract, results, passage verified)
pubmedfull study (doi)
Accumulating 9 minutes per day of short vigorous exercise is associated with 40% lower cancer-related mortality and 50% lower cardiovascular-related mortality in men and women.
"Now there's bigger studies showing men and women that exercise 9 minutes a day, the short vigorous types of exercise adding up, not 9 minutes altogether, but like a minute here, a minute there, a minute here, right? It adds up: 40% lower cancer-related mortality, 50% lower cardiovascular-related mortality." (said at 2:14:15)
The claim accurately reflects findings from a large prospective cohort study in the UK Biobank (Stamatakis et al., Nature Medicine 2022). In 25,241 non-exercisers (mean age 61.8 years, followed for an average of 6.9 years), accumulating brief 1- to 2-minute bursts of vigorous intermittent lifestyle physical activity (VILPA) throughout the day was associated with a 38-40% reduction in cancer mortality risk and a 48-49% reduction in cardiovascular disease (CVD) mortality risk compared to no VILPA. Because this is based on observational cohort data, residual confounding cannot be entirely ruled out, corresponding to moderate GRADE certainty.
GLP-1 receptor agonist medications increase the risk of gallstones.
"The other thing is gallstones. Um you're getting the increased risk of gallstones, right? Some people's gallbladder has to be removed." (said at 2:19:04)
A comprehensive systematic review and meta-analysis of 76 randomized clinical trials involving 103,371 patients published in JAMA Internal Medicine confirmed that GLP-1 receptor agonist use is associated with a significantly increased risk of gallbladder and biliary diseases (RR 1.37, 95% CI 1.23–1.52), specifically cholelithiasis (gallstones; RR 1.27, 95% CI 1.10–1.47) and cholecystitis (RR 1.36, 95% CI 1.14–1.62). The risk is particularly pronounced when these medications are prescribed at higher doses, for longer durations, or specifically for weight loss (RR 2.29, 95% CI 1.64–3.18).
- supports: Cholelithiasis in patients treated with Glucagon-Like Peptide-1 Receptor: An updated meta-… (Diabetes research and clinical practice 2020) · cited 31x in the literature
"GLP1-RA significantly increased the risk of cholelithiasis (MH-OR 1.28 [1.11, 1.48])." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and B… (JAMA internal medicine 2022) · cited 322x in the literature
"Among all included trials, randomization to GLP-1 RA treatment was associated with increased risks of gallbladder or biliary diseases (RR, 1.37; 95% CI, 1.23-1.52); specifically, cholelithiasis (RR, 1.27; 95% CI, 1.10-1.47), cholecystitis (RR, 1.36; 95% CI, 1.14-1.62), and biliary disease (RR, 1.55; 95% CI, 1.08-2.22)." (abstract, results, passage verified)
pubmedfull study (doi)
GLP-1 receptor agonist medications carry an FDA black box warning for thyroid cancer based on animal studies.
"There's a black box warning on them for thyroid cancer increase. That's never really been shown in human studies. It all comes from animal data, but it's there nonetheless." (said at 2:21:03)
GLP-1 receptor agonists carry an FDA boxed warning regarding the risk of thyroid C-cell tumors and medullary thyroid carcinoma (MTC). This regulatory warning is directly based on preclinical rodent carcinogenicity studies showing that sustained GLP-1 receptor activation induces C-cell hyperplasia and adenomas/carcinomas in rats and mice. In contrast, primate and human C-cells express vastly lower levels of GLP-1 receptors, and human clinical trials and primate models have not demonstrated corresponding C-cell proliferation or calcitonin increases.
During weight loss diets without resistance training and adequate protein, up to 40% of the total weight lost can come from lean mass.
"there's weight loss studies showing that in any weight loss diet, you know, if you're not eating enough protein and you're not resistance training, up to 40% of your weight can come from muscle weight loss that you're losing. I should say lean mass, including muscle." (said at 2:19:50)
During caloric restriction and weight loss without interventions such as adequate dietary protein and resistance training, lean body mass (fat-free mass, including skeletal muscle) typically accounts for approximately 20% to 30%, and can reach up to 40% to 50%, of total weight lost.
- supports: Sculpting Success: The Importance of Diet and Physical Activity to Support Skeletal Muscle… (Current developments in nutrition 2024) · cited 29x in the literature
"However, AOMs also reduce fat-free mass, including skeletal muscle, which has been demonstrated to account for 20% to 50% of total weight loss. This can equate to ~6 kg or 10% of total lean mass after 12-18 mo, a loss comparable to a decade of human aging. Despite questions surrounding the clinical relevance of weight loss-induced muscle loss, the importance of adopting lifestyle behaviors such as eating a protein-rich diet and incorporating regular resistance training to support skeletal muscle health, long-term weight loss maintenance, and overall well-being among AOM users should be encouraged." (abstract, background)
pubmedfull study (doi) - supports: Fat, muscle, and anti-obesity medications in cardiovascular disease prevention. (European heart journal 2026) · cited 4x in the literature
"Resistance training is currently the suggested strategy for preserving skeletal muscle and functional capacity during pharmacologic weight loss, while adjunctive strategies such as optimized protein intake and nutraceuticals may further mitigate muscle catabolism." (abstract, background, passage verified)
pubmedfull study (doi)
Omega-3 was the only supplement shown to slow aging in a study of healthy, physically active Swiss participants.
"That's been shown with omega-3. It's absolutely slowing aging. I told you omega-3 was the only supplement that was able to do that. Um, even in the context of people that were healthy and physically active. I mean, this the Swiss these Swiss people are healthy." (said at 2:35:55)
The statement accurately reflects a 2025 post hoc analysis of the DO-HEALTH randomized controlled trial (conducted across European centers including Switzerland in relatively healthy, active older adults). The study evaluated vitamin D3, omega-3, and exercise on four next-generation DNA methylation clocks of biological aging over 3 years. Omega-3 was the only individual supplement tested that demonstrated a statistically significant slowing of biological aging across multiple clocks (PhenoAge, GrimAge2, and DunedinPACE), with an effect size of 2.9 to 3.8 months over 3 years, although all three interventions combined showed additive benefits on PhenoAge. Epigenetic clocks serve as validated surrogate measures of biological aging.
- supports: Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation cloc… (Nature aging 2025) · cited 126x in the literature
"Omega-3 alone slowed the DNAm clocks PhenoAge, GrimAge2 and DunedinPACE, and all three treatments had additive benefits on PhenoAge. Overall, from baseline to year 3, standardized effects ranged from 0.16 to 0.32 units (2.9-3.8 months). In summary, our trial indicates a small protective effect of omega-3 treatment on slowing biological aging over 3 years across several clocks, with an additive protective effect of omega-3, vitamin D and exercise based on PhenoAge." (abstract, results, passage verified)
pubmedfull study (doi)
Sleep deprivation negatively affects blood glucose levels.
"I realized how important sleep was for my metabolic health. I thought I was doing everything right for metabolic health and and it was it was knowing how not getting enough sleep was affecting my glucose." (said at 2:36:23)
A 2022 systematic review and meta-analysis of randomized controlled trials (PMID: 35189549) examining sleep manipulation found that experimental sleep restriction significantly reduces whole-body insulin sensitivity and impairs glucose regulation as measured by oral or intravenous glucose tolerance tests and HOMA-IR. Extensive experimental literature consistently confirms that acute and chronic sleep restriction impairs glucose tolerance and metabolic control.
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.